Commodity Channel Index
|Bid||0.00 x 1000|
|Ask||0.00 x 1100|
|Day's Range||39.15 - 40.24|
|52 Week Range||28.41 - 49.32|
|Beta (5Y Monthly)||1.16|
|PE Ratio (TTM)||15.25|
|Forward Dividend & Yield||0.60 (1.53%)|
|Ex-Dividend Date||Feb 09, 2023|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for OPY
Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY) —announced today the completion of a Series C funding round for Perspectum, a United Kingdom-based medical imaging and diagnostic technology provider.
Oppenheimer & Co. Inc. ("Oppenheimer") – a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) – today announced its 33rd Annual Healthcare Conference will be held March 13 – 15. The virtual event will include a broad spectrum of over 225 public and private healthcare companies across all major sectors of the industry, including bio and specialty pharmaceuticals, biotechnology, medical devices, life science tools and diagnostics, and healthcare providers
Oppenheimer & Co. Inc. ("Oppenheimer") — a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY) — announced today the continued expansion of its Investment Grade desk with the additions of Perren Thomas, Dennis Megley and Mike Henneberry. Each will serve as Managing Directors on the Investment Grade Sales team in New York and report to Katie Lucas, Managing Director, and Head of Investment Grade Sales.